Harvard-trained ophthalmologists working alongside established, patent-holding scientists, engineers, and industry experts.
Management Team
Liane
Clamen, MD
Founder & CEO
Dr. Clamen is an ophthalmologist who earned her BA and MD at Harvard and completed her training at The Harvard Ophthalmology Residency Program at the Massachusetts Eye and Ear. She is the inventor of an Accommodating IOL, a punctal plug drug delivery system, and an anterior capsulotomy device.
Daniel Stanley, MS
Chief Operating Officer
Former Director of Intraocular Lens (IOL) Development at Alcon, Mr. Stanley has brought more than 30 IOL products from idea to market. With over 25 years of experience in the ophthalmology field, Mr. Stanley brings a wealth of experience to Adaptilens. He had lead roles on an R&D team that grew a medical device product line from $10M to $1B a year.
Earlier in his career, Mr. Stanley was an Air Force Officer and rocket propulsion engineer.
Brett Thomes, PhD
Chief Information and Technology Officer
Former Senior Director of Process Development at Alcon, Dr. Thomes has extensive experience and knowledge in R&D and Manufacturing of IOLs. An award-winning process development leader, Dr. Thomes has over 20 years of experience in the ophthalmology field and has led a global R&D team during his time at Alcon. Dr. Thomes has a track record of achievements in delivering a broad range of Class I/II/III medical devices to the market.
Scientific Advisory Board
Sheila Borboli-Gerogiannis,
MD, FACS
Member, Scientific Advisory Board
Dr. Borboli-Gerogiannis is a Harvard-trained ophthalmologist who specializes in cataract surgery and corneal disease. She serves as Site Director of the Mass Eye and Ear Longwood and is a member of the Comprehensive Ophthalmology and Cataract Consultation Service at the Mass Eye and Ear.
An Assistant Professor of Ophthalmology at Harvard Medical School, Dr. Borboli-Gerogiannis is a well-respected medical educator whose primary focus is teaching resident physicians how to perform cataract surgery.
Thomas Clinch,
MD
Member, Scientific Advisory Board
Dr. Clinch is the founding partner of Eye Doctors of Washington and has practiced ophthalmology for more than 30 years. He has performed over 40,000 LASIK and 20,000 cataract procedures. He was educated at Cornell, Jefferson Medical College, and the Wills Eye Hospital.
Throughout his award-winning career, Dr. Clinch has provided innovative, state-of-the-art care. He has served as an investigator in more than 30 clinical studies pertaining to LASIK, PRK, and a variety of IOLs. Dr. Clinch has presented 100+ professional presentations and has authored over 40 scientific articles
Elizabeth Yeu,
MD
Member, Scientific Advisory Board
Dr. Yeu is the current President of the American Society of Cataract and Refractive Surgery (ASCRS, 2023-2024). She is a partner at Virginia Eye Consultants, and an Assistant Professor of Ophthalmology at the Eastern Virginia Medical School. Dr. Yeu trained at the Baylor College of Medicine.
Dr Yeu has authored hundreds of publications and delivered hundreds of invited lectures. She is internationally recognized in her expert areas of refractive cataract surgery, complex lens-based surgeries, and ocular surface disease management. Dr. Yeu currently serves as the Chief Medical Advisor for Tarsus Pharmaceuticals.
Mathew L
Becker, PhD
Member, Scientific Advisory Board
Professor Becker teaches Chemistry, Mechanical Engineering, Materials Science, and Biomedical Engineering at Duke University. He has won many awards, including the 2019 Carl S. Marvel Award in Creative Polymer Chemistry from the American Chemical Society.
He is the author of 170+ papers, and holds 110+ issued or pending patents.
Thomas X
Neenan, PhD
Member, Scientific Advisory Board
A successful serial entrepreneur, Dr. Neenan is the Principal of Gray Door Partners LLC, a practice that develops university-based spinouts in science and biotech.
He is the author of 60+ publications and book chapters, and holds 45+ US and international patents.
Brian Levy,
OD, MSc
Member, Scientific Advisory Board
A proven leader in the field of Ophthalmology, Dr. Levy has extensive experience in Drug and Device Development. Dr. Levy was Chief Medical Officer of Bausch & Lomb and then Aerie Pharmaceuticals. He is currently Chief Executive Officer of OcuNexus Therapeutics, developing medications to treat chronic sight-threatening diseases.
He is a Clinical Professor in the Department of Ophthalmology at the University of Rochester’s School of Medicine and is the author of 50+ publications in peer-reviewed journals.
Cindy Chao,
MD, PhD
Member, Scientific Advisory Board
Dr. Chao earned her MD and PhD in molecular genetics from Harvard following her BS and MS from MIT. She completed her training at The Harvard Ophthalmology Residency Program at the Massachusetts Eye and Ear.
Dr. Chao was in clinical practice for 20 years, most recently at Ophthalmic Consultants of Boston. She specialized in cataract surgery and corneal conditions.
Adaptilens Board
Liane Clamen, MD.
Founder, CEO, and Member, Adaptilens Board
Founder and CEO Liane Clamen, MD, is an ophthalmologist who earned her BA and MD at Harvard and completed her training at the Harvard Ophthalmology Residency Program at the Massachusetts Eye and Ear. She is the inventor of the Adaptilens Accommodating IOL, a punctal plug drug delivery system, and an anterior capsulotomy device. She has studied and written extensively about cataract surgery and intraocular lenses for more than 20 years.
Terry Kim, MD
Member, Adaptilens Board
Past president of the American Society of Cataract and Refractive Surgery (ASCRS), Dr. Terry Kim is Professor of Ophthalmology and Division Chief of Cornea, External Disease, and Refractive Surgery at Duke University Eye Center. Dr. Kim is a world-renowned ophthalmologist who has published over 400 peer-reviewed journal articles, textbook chapters, and scientific abstracts, and has delivered over 400 invited lectures, including numerous named lectureships. He has received many awards, including the Achievement Award from the American Academy of Ophthalmology (AAO).
Robert ("Bob") Doris, JD, MBA
Member, Adaptilens Board
Mr. Doris is the Founding Partner of Accanto Partners, a seed-stage investor in startup companies. Previously, he founded and led Sonic Solutions from inception, as CEO (1986 – 2005) and later as Chairman (2005 – 2011). Sonic developed software and hardware tools for professional digital audio and digital video, with special focus on CD and DVD creation, and was recognized with a technical Emmy® award in 1996. Mr. Doris led Sonic’s successful IPO in 1994 and oversaw later developments as Sonic offered consumer tools for digital media creation including Roxio™ and Divx™ branded offerings, prior to the successful sale of Sonic to Rovi Corporation in 2011.
William F. Shea, MBA
Member, Adaptilens Board
Mr. Shea has over 40 years of medical device leadership. He has served as CEO for three medical companies, and as a Board Member for over a dozen other medical companies. Mr. Shea began his career at The Kendal Company (now part of Medtronic) and later served as CEO of New Dimensions in Medicine, The Clinipad Corporation, and Med-Ecom. Bill has also consulted on numerous medical device transactions representing entrepreneurs with innovative technologies that fit in the portfolios of larger strategic medical companies. He holds a BA degree in Economics from College of The Holy Cross and an MBA from Boston University.
Jamie Goldstein, MBA
Member, Adaptilens Board
Mr. Goldstein is Founding Partner at Pillar VC. He has spent over two decades working in venture capital. Prior to Pillar, Mr. Goldstein was an investing partner for 18 years at North Bridge Venture Partners.
John Andres, JD
Member, Adaptilens Board
Mr. Andres is a patent attorney who has over 30 years of experience in the medical device industry in legal and business roles. He served as VP and Co-General Counsel at US Surgical Corporation, and as Director at K2M Inc.
We're making:
An intraocular lens that imitates the young, healthy, human lens so that patients will have near, intermediate, and distance vision without eyeglasses or contact lenses.
